Reaction Details |
| Report a problem with these data |
Target | Cannabinoid receptor 2 |
---|
Ligand | BDBM50272598 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_510487 (CHEMBL1006428) |
---|
Ki | 1±n/a nM |
---|
Citation | Cheng, Y; Albrecht, BK; Brown, J; Buchanan, JL; Buckner, WH; DiMauro, EF; Emkey, R; Fremeau, RT; Harmange, JC; Hoffman, BJ; Huang, L; Huang, M; Lee, JH; Lin, FF; Martin, MW; Nguyen, HQ; Patel, VF; Tomlinson, SA; White, RD; Xia, X; Hitchcock, SA Discovery and optimization of a novel series of N-arylamide oxadiazoles as potent, highly selective and orally bioavailable cannabinoid receptor 2 (CB2) agonists. J Med Chem51:5019-34 (2008) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Cannabinoid receptor 2 |
---|
Name: | Cannabinoid receptor 2 |
Synonyms: | CANNABINOID CB2 | CB-2 | CB2 | CB2A | CB2B | CNR2 | CNR2_HUMAN | CX5 | Cannabinoid CB2 receptor | Cannabinoid receptor 2 (CB2) | Cannabinoid receptor 2 (CB2R) | hCB2 |
Type: | G Protein-Coupled Receptor (GPCR) |
Mol. Mass.: | 39690.94 |
Organism: | Homo sapiens (Human) |
Description: | P34972 |
Residue: | 360 |
Sequence: | MEECWVTEIANGSKDGLDSNPMKDYMILSGPQKTAVAVLCTLLGLLSALENVAVLYLILS
SHQLRRKPSYLFIGSLAGADFLASVVFACSFVNFHVFHGVDSKAVFLLKIGSVTMTFTAS
VGSLLLTAIDRYLCLRYPPSYKALLTRGRALVTLGIMWVLSALVSYLPLMGWTCCPRPCS
ELFPLIPNDYLLSWLLFIAFLFSGIIYTYGHVLWKAHQHVASLSGHQDRQVPGMARMRLD
VRLAKTLGLVLAVLLICWFPVLALMAHSLATTLSDQVKKAFAFCSMLCLINSMVNPVIYA
LRSGEIRSSAHHCLAHWKKCVRGLGSEAKEEAPRSSVTETEADGKITPWPDSRDLDLSDC
|
|
|
BDBM50272598 |
---|
n/a |
---|
Name | BDBM50272598 |
Synonyms: | 6-Methoxy-5-(2-morpholin-4-yl-ethyl)-2-(1,3,3-trimethyl-bicyclo[2.2.1]hept-2-yl)-2,5-dihydro-pyrido[4,3-b]indol-1-one | 6-methoxy-5-(2-morpholinoethyl)-2-((1S,2S,4R)-1,3,3-trimethylbicyclo[2.2.1]heptan-2-yl)-2H-pyrido[4,3-b]indol-1(5H)-one | CHEMBL527031 |
Type | Small organic molecule |
Emp. Form. | C28H37N3O3 |
Mol. Mass. | 463.6117 |
SMILES | COc1cccc2c1n(CCN1CCOCC1)c1ccn([C@H]3[C@@]4(C)CC[C@H](C4)C3(C)C)c(=O)c21 |r| |
Structure |
|